Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Valine, a branched-chain amino Acid, reduced HCV viral load and led to eradication of HCV by interferon therapy in a decompensated cirrhotic patient.

Kawaguchi T, Torimura T, Takata A, Satomi S, Sata M.

Case Rep Gastroenterol. 2012 Sep;6(3):660-7. doi: 10.1159/000343094. Epub 2012 Oct 24.

2.

Valine, the branched-chain amino acid, suppresses hepatitis C virus RNA replication but promotes infectious particle formation.

Ishida H, Kato T, Takehana K, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T.

Biochem Biophys Res Commun. 2013 Jul 19;437(1):127-33. doi: 10.1016/j.bbrc.2013.06.051. Epub 2013 Jun 24.

PMID:
23806690
3.

Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: A propensity score analysis.

Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Niinomi T, Ito T, Hasegawa R, Ando Y, Yamamoto K, Tanaka T.

Hepatol Res. 2014 Mar;44(3):288-95. doi: 10.1111/hepr.12120. Epub 2013 Apr 29.

PMID:
23607436
4.

Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.

De Mitri MS, Morsica G, Chen CH, Mele L, Baccarini P, Chianese R, Piccinini A, Lazzarin A, Pisi E.

Ital J Gastroenterol Hepatol. 1997 Jun;29(3):255-61.

PMID:
9646218
5.

Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice.

Korenaga M, Nishina S, Korenaga K, Tomiyama Y, Yoshioka N, Hara Y, Sasaki Y, Shimonaka Y, Hino K.

Liver Int. 2015 Apr;35(4):1303-14. doi: 10.1111/liv.12675. Epub 2014 Sep 18.

6.

A review of the treatment of chronic hepatitis C virus infection in cirrhosis.

Vezali E, Aghemo A, Colombo M.

Clin Ther. 2010 Dec;32(13):2117-38. doi: 10.1016/S0149-2918(11)00022-1. Review.

PMID:
21316532
7.

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.

Am J Gastroenterol. 2003 May;98(5):1150-4.

PMID:
12809841
8.

Improvement in the Amino Acid Imbalance in Hepatitis C Virus Infected Patients After Viral Eradication by Interferon Treatment.

Enomoto H, Nishikawa H, Ikeda N, Aizawa N, Sakai Y, Yoh K, Takata R, Hasegawa K, Nakano C, Nishimura T, Ishii A, Takashima T, Iwata Y, Iijima H, Nishiguchi S.

Hepat Mon. 2016 May 23;16(6):e35824. doi: 10.5812/hepatmon.35824. eCollection 2016 Jun.

9.

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.

Liver Transpl. 2004 Feb;10(2):199-207.

10.

Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.

El Raziky M, Attia D, El Akel W, Shaker O, Khatab H, Abdo S, Elsharkawy A, Esmat G.

Arab J Gastroenterol. 2013 Sep;14(3):94-8. doi: 10.1016/j.ajg.2013.08.005. Epub 2013 Oct 10.

PMID:
24206736
11.

Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis.

Tmu N, Kumar A, Sharma P, Singla V, Bansal N, Arora A.

J Clin Exp Hepatol. 2019 Jan-Feb;9(1):4-12. doi: 10.1016/j.jceh.2018.02.009. Epub 2018 Mar 6.

PMID:
30765933
12.

Heating improves poor compliance with branched chain amino acid-rich supplementation in patients with liver cirrhosis: A before-after pilot study.

Itou M, Kawaguchi T, Taniguchi E, Shiraishi S, Ibi R, Mutou M, Okada T, Uchida Y, Otsuka M, Oriishi T, Tanaka S, Takakura M, Mitsuyama K, Tsuruta O, Sata M.

Mol Med Rep. 2009 Nov-Dec;2(6):983-7. doi: 10.3892/mmr_00000202.

PMID:
21475931
13.

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

Morisco F, Granata R, Stroffolini T, Guarino M, Donnarumma L, Gaeta L, Loperto I, Gentile I, Auriemma F, Caporaso N.

World J Gastroenterol. 2013 May 14;19(18):2793-8. doi: 10.3748/wjg.v19.i18.2793.

14.

High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy.

Ji F, Zhou R, Wang W, Bai D, He C, Cai Z, Shen Y, Wang S, Deng H, Li Z.

J Interferon Cytokine Res. 2017 Aug;37(8):362-368. doi: 10.1089/jir.2017.0040. Epub 2017 Jul 21.

PMID:
28731786
15.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.

Hepatology. 2001 Dec;34(6):1193-9.

PMID:
11732009
16.

A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients. Tokyo-Chiba Hepatitis Research Group.

Shiratori Y, Moriyama M, Imazeki F, Ohkubo H, Tanaka N, Arakawa Y, Yoshida H, Yokosuka O, Shibuya A, Matsuzaki K, Hashimoto E, Hayashi N, Hirata K, Ohashi Y, Omata M.

Liver. 2000 Jul;20(4):271-80.

PMID:
10959805
17.

Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.

Hsu CS, Liu CH, Liu CJ, Wang CC, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH.

Am J Gastroenterol. 2009 Mar;104(3):598-604. doi: 10.1038/ajg.2008.125. Epub 2009 Feb 10.

PMID:
19262519
18.

[Chronic hepatitis C].

Grammatikos G, Sarrazin C.

Dtsch Med Wochenschr. 2010 Dec;135(50):2525-34; quiz 2535-8. doi: 10.1055/s-0030-1269423. Epub 2010 Dec 7. Review. German.

PMID:
21140330
19.

Management of Cirrhotic Patients After Successful HCV Eradication.

Kwok RM, Tran TT.

Curr Treat Options Gastroenterol. 2017 Jun;15(2):305-315. doi: 10.1007/s11938-017-0134-2. Review.

PMID:
28439747
20.

Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.

Nakamura H, Ogawa H, Kuroda T, Yamamoto M, Enomoto H, Kishima Y, Yoshida K, Ito H, Matsuda M, Noguchi S.

Hepatogastroenterology. 2002 Sep-Oct;49(47):1373-6.

PMID:
12239945

Supplemental Content

Support Center